Progesterone receptor and human epidermal growth factor receptor 2 status: An independent influence on the efficacy of endocrine therapy in breast cancer? Reply

被引：1
|
作者：
Dowsett, M [1 ]
Cuzick, J
Wale, C
Howell, T
Houghton, J
Baum, M
Buzdar, A
机构：
[1] Royal Marsden NHS Fdn Trust, London, England
[2] Barts & London Queen Marys Sch Med & Dent, Wolfson Inst Prevent Med, London, England
[3] Christie Hosp NHS Trust, Manchester M20 4BX, Lancs, England
[4] UCL Hosp NHS Trust, London, England
[5] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 09期
关键词：
D O I：
10.1200/JCO.2005.05.1623
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1482 / 1482
页数：1
相关论文
共 50 条
  • [31] A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases
    Aurilio, Gaetano
    Disalvatore, Davide
    Pruneri, Giancarlo
    Bagnardi, Vincenzo
    Viale, Giuseppe
    Curigliano, Giuseppe
    Adamoli, Laura
    Munzone, Elisabetta
    Sciandivasci, Angela
    De Vita, Fernando
    Goldhirsch, Aron
    Nole, Franco
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (02) : 277 - 289
  • [32] Molybdenum Target X-Ray Features and Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 in Invasive Breast Cancer
    Tailaiti, Gulijire
    Maimaiti, Gulanbaier
    Aikeremu, Youlituzi
    Tuerdi, Batuer
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 2777 - 2783
  • [33] Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression
    Lindstrom, Linda Sofie
    Karlsson, Eva
    Wilking, Ulla M.
    Johansson, Ulla
    Hartman, Johan
    Lidbrink, Elisabet Kerstin
    Hatschek, Thomas
    Skoog, Lambert
    Bergh, Jonas
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) : 2601 - 2608
  • [34] Effect of neoadjuvant chemotherapy on expressions of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, and Ki-67 in breast cancer
    Qin Qinghong
    Gao Fangfang
    Jiang Wei
    Tan Qixing
    Mo Qinguo
    Wei Changyuan
    中华医学杂志（英文版）, 2014, (18) : 3272 - 3277
  • [35] Immunoexpression of claudin-4 and correlation with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-neu in breast cancer
    Kumar, Niranjan
    Tandon, Megha
    Chintamani, C. M.
    Saxena, Sunita
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (06) : 1766 - 1770
  • [36] Epidermal growth factor receptor levels in progesterone receptor positive breast tumors
    Monroy Anton, J. L.
    Soler Tortosa, M.
    Lopez-Munoz, M.
    Navarro Bergada, A.
    EJC SUPPLEMENTS, 2005, 3 (02): : 89 - 89
  • [37] Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor α in breast cancer cells
    Yang, ZB
    Barnes, CJ
    Kumar, R
    CLINICAL CANCER RESEARCH, 2004, 10 (11) : 3621 - 3628
  • [38] Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer
    Aurilio, Gaetano
    Monfardini, Lorenzo
    Rizzo, Stefania
    Sciandivasci, Angela
    Preda, Lorenzo
    Bagnardi, Vincenzo
    Disalvatore, Davide
    Pruneri, Giancarlo
    Munzone, Elisabetta
    Della Vigna, Paolo
    Renne, Giuseppe
    Bellomi, Massimo
    Curigliano, Giuseppe
    Goldhirsch, Aron
    Nole, Franco
    ACTA ONCOLOGICA, 2013, 52 (08) : 1649 - 1656
  • [39] Human Epidermal Growth Factor Receptor 2 "Low" in Breast Cancer in 2023
    Laffer, Shabnam
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2023, 147 (09) : 989 - 990
  • [40] Discordant Human Epidermal Growth Factor Receptor 2 and Hormone Receptor Status in Primary and Metastatic Breast Cancer and Response to Trastuzumab
    Chang, Hye Jung
    Han, Sae-Won
    Oh, Do-Youn
    Im, Seock-Ah
    Jeon, Yoon Kyung
    Park, In Ae
    Han, Wonshick
    Noh, Dong-Young
    Bang, Yung-Jue
    Kim, Tae-You
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (05) : 593 - 599
12345